Zimin Tang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Zimin Tang

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Lancet (London, England)|February 22, 2024

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trialShoujie Huang, Xuefeng Zhang, Yingying Su, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025

Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variantsSiling Wang, Hui Sun, Yizhen Wang, et al.

Journal of Hepatology|June 26, 2025

Antibodies elicited by hepatitis E vaccination in humans confer cross-genus protection against rat hepatitis E virusZihao Chen, Liqin Liu, Jianwen Situ, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Lancet (London, England)|February 22, 2024

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trialShoujie Huang, Xuefeng Zhang, Yingying Su, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025

Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variantsSiling Wang, Hui Sun, Yizhen Wang, et al.

Journal of Hepatology|June 26, 2025

Antibodies elicited by hepatitis E vaccination in humans confer cross-genus protection against rat hepatitis E virusZihao Chen, Liqin Liu, Jianwen Situ, et al.

Pageof 3